Study of the Insomnia in Patients With Low Back Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Primary Insomnia
Interventions
DRUG

Eszopiclone

Eszopiclone 3 mg po nightly for duration of study blind phase.

DRUG

Placebo

Placebo nightly over duration of double blind study phase

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

Duke University

OTHER

NCT00365976 - Study of the Insomnia in Patients With Low Back Pain | Biotech Hunter | Biotech Hunter